PATH | VRL
Menu

Find resources

Total results with these characteristics: 207

Disease: Meningococcus

Page 5 of 11
Immunize Canada

This partnership of nongovernmental, professional, health, consumer, government, and private-sector organizations aims to promote the understanding and use of vaccines recommended by Canada's National Advisory Committee on Immunization. Its goal is …

Author: Immunize Canada

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

This article, published in The New England Journal of Medicine, discusses the methods and results of two studies conducted in Africa to evaluate a new meningococcal A conjugate vaccine. The conclusion of the studies is that the new vaccine has a …

Author: Sow SO, Okoko BJ, Diallo A, et al.

Publication date: 2011

Immunogenicity and Safety of a New Meningococcal A Conjugate Vaccine in Indian Children Aged 2-10 Years: A Phase II/III Double-Blind Randomized Controlled Trial

This article, published in Vaccine, describes a study that compared the immunogenicity and safety of a single dose of a new meningococcal A conjugate vaccine (PsA-TT, MenAfriVac™, Serum Institute of India Ltd.) against the meningococcal group …

Author: Hirve S, Bavdekar A, Pandit A, et al.

Publication date: 2012

The Immunological Basis for Immunization Series

This web page provides links to individual disease/vaccine-specific modules that are intended to give immunization managers and vaccination professionals a brief and easy-to-understand overview of the scientific basis of vaccination, as well as the …

Author: World Health Organization

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

This article, published in the Journal of Infectious Diseases, investigates the impact of meningococcal serogroup C conjugate vaccine introduction in the United Kingdom on asymptomatic carriage of meningococci to establish whether …

Author: Maiden MCJ, Ibarz-Pavón AB, Urwin R, et al.

Publication date: 2008

The Impact of Protein-Conjugate Polysaccharide Vaccines: An Endgame for Meningitis?

The impact of conjugate polysaccharide vaccines on disease is largely due to their effectiveness against asymptomatic carriage of bacteria. This reduces transmission, resulting in herd immunity; however, the effect on carriage can result in the …

Author: Maiden MCJ

Publication date: 2013

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1 to 29-year-olds in Burkina Faso in 2010. The authors of this article, published in Clinical Infectious …

Author: Kristiansen PA, Diomandé F, Ba AK, et al.

Publication date: 2013

Implementation of Standard Operating Procedures for Enhanced Meningitis Surveillance in 13 Countries of the African Meningitis Belt from 2003 to 2008

This poster, presented at the 2008 International Pathogenic Neisseria Conference, displays the results of a study to determine the effectiveness of the Standard Operating Procedures that were developed in 2001 to 2002 to codify and enhance …

Author: Djingarey MH, Konde K, Kandolo D, et al.

Publication date: 2008

The Implications of Vaccines for Prevention of Bacterial Meningitis

Although existing conjugate vaccines protect against some types of bacterial meningitis, new vaccines are needed to broaden protection against the disease. Published in Current Opinion in Neurology, this article posits new uses for existing vaccines …

Author: Riordan A

Publication date: 2010

Increased Incidence of Meningococcal Disease in HIV-Infected Individuals Associated With Higher Case-Fatality Ratios in South Africa

This article, published in AIDS, describes a cohort surveillance study conducted in South Africa to compare the incidence of meningococcal disease among HIV-infected individuals versus uninfected individuals. The authors also evaluated the extent to …

Author: Cohen C, Singh E, Wu HM, et al.

Publication date: 2010

Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

This website from the Indian Academy of Pediatrics provides up-to-date information on vaccination for the general public and heath care professionals. It provides a range of resources including information about the latest recommendations by the …

Author: Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

Infectious Disease: An Ill Wind, Bringing Meningitis

This commentary, published in the journal Science, discusses meningococcal meningitis epidemics in Africa that come with the onset of the dry season, and the vaccines in development that could limit the disease's impact. ABSTRACT ONLY. (Learn …

Author: Roberts L

Publication date: 2008

Infectious Disease: Hitting Early, Epidemic Meningitis Ravages Nigeria and Niger

This commentary, published in the journal Science, discusses one of the worst meningococcal meningitis epidemics in years in Nigeria and Niger. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal …

Author: Roberts L

Publication date: 2009

Intercountry Meningitis Meeting: Preparing for the Next Epidemic Seasons, Mali, October 2006

This article, published in the World Health Organization's Weekly Epidemiological Record, summarizes an intercountry meeting on enhanced surveillance and responses to meningitis epidemics held in October 2006 in Bamako, Mali. More than 80 …

Author: World Health Organization

Publication date: 2007

Introducing New Vaccines Into Developing Countries: Obstacles, Opportunities, and Complexities

This commentary, published in Nature Medicine, reviews current trends that may affect whether the most promising of the 350 vaccine candidates under development will eventually be used in programs for the poor in developing countries. It also …

Author: Clemens J, Jodar L

Publication date: 2005

Invasive Meningococcal Disease Epidemiology and Control Measures: A Framework for Evaluation

This article, published in BMC Public Health, describes a discrete event simulation of the epidemiology of invasive meningococcal disease to quantify the potential impact of implementing routine vaccination of adolescents in the United States with a …

Author: Caro JJ, Möller J, Getsios D, et al.

Publication date: 2007

Investigation of Different Group A Immunoassays Following One Dose of Meningococcal Group A Conjugate Vaccine or A/C Polysaccharide Vaccine in Adults

This article, published in Clinical and Vaccine Immunology, details further analysis of the sera from a previous Phase 1 study to assess the safety, immunogenicity, and antibody persistence of a new group A conjugate vaccine, using four additional …

Author: Findlow H, Plikaytis BD, Aase A, et al.

Publication date: 2009

Is it Exposure to Cigarette Smoke or to Smokers Which Increases the Risk of Meningococcal Disease in Teenagers?

This article, published in the International Journal of Epidemiology, reports on a study that aimed to determine whether passive smoking, which appears to increase the risk of meningococcal disease in adolescents, is attributable to …

Author: Coen PG, Tully J, Stuart JM, et al.

Publication date: 2006

Joint Vaccine Education Resource Center

This website provides resources in the field of immunization, including an extensive selection of peer-reviewed articles from the literature as well as links to valuable resources for scientists, clinicians, and patients focused on the most commonly …

Author: American Journal of Preventative Medicine; Vaccine

Kill or Cure: Meningitis

This 25-minute BBC World documentary, produced by Rockhopper TV, offers a poignant and revealing account of the devastating impact meningitis epidemics have on individuals, families, and communities. The film also takes viewers to Mali where PATH's …

Author: PATH; Rockhopper TV

Publication date: 2007

Page 5 of 11